Acesso livre
Acesso livre

Covid-19 (Temas de Saúde Pública)

Por que a terceira dose de vacina contra COVID-19 é importante para pessoas imunocomprometidas?

2 Set, 2021 | 11:49h

Why is a third COVID-19 vaccine dose important for people who are immunocompromised? – The Conversation

Conteúdos relacionados:

FDA authorizes additional Covid-19 vaccine dose for certain immunocompromised individuals – Other fully vaccinated individuals do not need an additional vaccine dose right now.

RCT: third dose of Moderna mRNA vaccine increases immunity in transplant recipients.

Study: Among kidney transplant recipients who did not respond after 2 doses, a third dose of an mRNA-1273 vaccine induced a serologic response in 49% of patients.

Case series: Safety and immunogenicity of a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients.


Perspectiva | Reforços da vacina contra COVID-19 em nações ricas atrasará a vacinação para todos.

2 Set, 2021 | 11:48h

COVID-19 boosters in rich nations will delay vaccines for all – Nature

 

Comentários no Twitter

 


COVID pode ser mais infecciosa nos 2 ou 3 dias próximos ao início dos sintomas.

2 Set, 2021 | 11:43h

COVID may be most infectious 2 or 3 days around symptom onset – CIDRAP

Artigo original: COVID-19 Transmission Dynamics Among Close Contacts of Index Patients With COVID-19: A Population-Based Cohort Study in Zhejiang Province, China – JAMA Internal Medicine


Estudo demonstra imunogenicidade humoral significativamente mais alta induzida pela vacina da Moderna em comparação à vacina da Pfizer- BioNTech.

2 Set, 2021 | 11:28h

Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273 – JAMA

Conteúdos relacionados:

Moderna may be superior to Pfizer against Delta variant — breakthrough odds rise with time.

[Preprint] Pfizer vs. Moderna COVID-19 vaccine effectiveness against the Delta variant in Qatar – Effectiveness against symptomatic disease due to Delta was 53.5% for Pfizer and 84.8% for Moderna; effectiveness against severe disease due to Delta was 89.7% for Pfizer and 100.0% for Moderna.


OMS emite diretrizes para o “passaporte digital” da vacina contra COVID-19 – mas destaca que ele não deve ser requisito para viagens.

2 Set, 2021 | 11:26h

WHO Issues COVID-19 Digital ‘Vaccine Pass’ Guidelines – But Stresses These Should Not be Requirements for Travel – Health Policy Watch

Ver diretriz: Digital documentation of COVID-19 certificates: vaccination status: technical specifications and implementation guidance, 27 August 2021 – World Health Organization


Estudo mostra que as crianças ganharam peso durante a pandemia.

2 Set, 2021 | 11:22h

News release: Young children gained weight during the pandemic – Kaiser Permanente

Estudo original: Changes in Body Mass Index Among Children and Adolescents During the COVID-19 Pandemic – JAMA

 

Comentário no Twitter

 


Opinião | Vacinas contra COVID: precisamos descobrir quais incentivos funcionam de fato – os autores argumentam que políticas para promover a adesão às vacinas devem ser testadas em estudos clínicos randomizados.

2 Set, 2021 | 11:17h

COVID vaccines: we need to find out which incentives actually work – The Conversation


Estudo de coorte | Pacientes com Covid-19 infectados pela variante Delta são 2 vezes mais suscetíveis à necessidade de admissão hospitalar ou atendimento de emergência.

30 Ago, 2021 | 13:41h

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study – The Lancet Infectious Diseases

Comentários:

Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants – The Lancet Infectious Diseases

Covid: Delta variant patients twice as likely to need hospital care – BBC

Covid-19 hospitalization risk doubles with Delta variant, UK study suggests – CNN

Expert reaction to study looking at risk of hospitalisation from the delta variant compared with alpha – Science Media Centre

 

Comentário no Twitter

 


Estudo com mais de 2 milhões de pessoas na Inglaterra mostra que a Covid-19, e não a vacinação, apresenta os maiores riscos de coágulos sanguíneos.

30 Ago, 2021 | 13:39h

Comunicado de imprensa: Covid-19, not vaccination, presents biggest blood clot risks – University of Oxford

Estudo original: Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study – The BMJ

Editorial: Strengthening international surveillance of vaccine safety – The BMJ

Comentários:

Expert reaction to study looking at risk of thrombocytopenia and thromboembolism after COVID-19 vaccination and SARS-CoV-2 infection – Science Media Centre

Covid: Vaccine complications dwarfed by virus risks – BBC

 

Comentário no Twitter

 


Muitos previram algum tipo de declínio no aprendizado sobre Covid (“Covid slide”). Resultados de teste mostram o quanto isso é ruim.

30 Ago, 2021 | 13:38h

Many predicted some kind of ‘Covid slide’ in learning. Test results show how bad it is – CNN

Relatório: Learning during COVID-19: Reading and math achievement in the 2020-21 school year – NWEA

Conteúdo relacionado: [Preprint] Impact of the COVID-19 pandemic on early child cognitive development: initial findings in a longitudinal observational study of child health.


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.